Literature DB >> 19110288

HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand.

David Wilson1, A Kace Keiluhu, Suphawadee Kogrum, Tony Reid, Noppadol Seriratana, Nathan Ford, Moe Kyawkyaw, Phol Talangsri, Nattayapa Taochalee.   

Abstract

This paper describes a program to increase patients' treatment literacy regarding viral load (VL) monitoring through patient education materials and a counseling protocol, implemented by peer counselors, in order to reinforce adherence to first-line treatment. VL monitoring and second-line antiretroviral treatment were introduced into an established first-line treatment program in a rural district hospital in Thailand. All patients (171 adults and 14 children) taking antiretroviral treatment for more than 6 months participated and those with detectable VL were targeted for additional adherence support. The main outcome measure recorded was the number of detectable results becoming undetectable after counseling. Four adults and one child had a persistently high VL and switched to second-line treatment. Of 51 adults (30%) with an initial low detectable VL, 47/51 identified likely explanations, usually linked with poor adherence. Following counseling, VL became undetectable in 45/51 cases and some patients could resolve long-standing psychosocial problems. We conclude that HIV-1 VL monitoring together with targeted counseling for patients with detectable VL can promote adherence to treatment, providing an opportunity to delay onset of HIV-1 resistance. When implemented with a patient-centered approach, it can be a very useful tool for psychosocial support.

Entities:  

Mesh:

Year:  2008        PMID: 19110288     DOI: 10.1016/j.trstmh.2008.11.007

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  29 in total

Review 1.  Interventions to improve adherence to antiretroviral therapy in children with HIV infection.

Authors:  Deborah Bain-Brickley; Lisa M Butler; Gail E Kennedy; George W Rutherford
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.

Authors:  Luisa Salazar-Vizcaya; Olivia Keiser; Mary-Ann Davies; Andreas D Haas; Nello Blaser; Vivian Cox; Brian Eley; Helena Rabie; Harry Moultrie; Janet Giddy; Robin Wood; Matthias Egger; Janne Estill
Journal:  AIDS       Date:  2014-10-23       Impact factor: 4.177

3.  Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration.

Authors:  Mary-Ann Davies; Andrew Boulle; Brian Eley; Harry Moultrie; Karl Technau; Helena Rabie; Gilles van Cutsem; Janet Giddy; Robin Wood; Matthias Egger; Olivia Keiser
Journal:  Trop Med Int Health       Date:  2011-08-11       Impact factor: 2.622

Review 4.  Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review.

Authors:  James H McMahon; Julian H Elliott; Silvia Bertagnolio; Rachel Kubiak; Michael R Jordan
Journal:  Bull World Health Organ       Date:  2013-02-21       Impact factor: 9.408

5.  Prospective evaluation of diagnostic accuracy of dried blood spots from finger prick samples for determination of HIV-1 load with the NucliSENS Easy-Q HIV-1 version 2.0 assay in Malawi.

Authors:  Emmanuel Fajardo; Carol A Metcalf; Pascale Chaillet; Lucia Aleixo; Pieter Pannus; Isabella Panunzi; Laura Triviño; Tom Ellman; Andrew Likaka; Reuben Mwenda
Journal:  J Clin Microbiol       Date:  2014-02-05       Impact factor: 5.948

6.  Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.

Authors:  Victoria Johnston; Katherine L Fielding; Salome Charalambous; Gavin Churchyard; Andrew Phillips; Alison D Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

7.  The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.

Authors:  Mary-Ann Davies; Andrew Boulle; Karl Technau; Brian Eley; Harry Moultrie; Helena Rabie; Daniela Garone; Janet Giddy; Robin Wood; Matthias Egger; Olivia Keiser
Journal:  Trop Med Int Health       Date:  2012-09-14       Impact factor: 2.622

8.  Durable HIV RNA resuppression after virologic failure while remaining on a first-line regimen: a cohort study.

Authors:  Christopher J Hoffmann; Salome Charalambous; Alison D Grant; Lynn Morris; Gavin J Churchyard; Richard E Chaisson
Journal:  Trop Med Int Health       Date:  2014-02       Impact factor: 2.622

9.  Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.

Authors:  Janet M Raboud; Mona R Loutfy; DeSheng Su; Ahmed M Bayoumi; Marina B Klein; Curtis Cooper; Nima Machouf; Sean Rourke; Sharon Walmsley; Anita Rachlis; P Richard Harrigan; Marek Smieja; Christos Tsoukas; Julio S G Montaner; Robert S Hogg
Journal:  BMC Infect Dis       Date:  2010-02-25       Impact factor: 3.090

10.  Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay.

Authors:  Sumathi Sivapalasingam; Beatrice Wangechi; Fatuma Marshed; Maura Laverty; Shaffiq Essajee; Robert S Holzman; Fred Valentine
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.